Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
46.3M
-
Shares change
-
+7.43M
-
Total reported value, excl. options
-
$589M
-
Value change
-
+$135M
-
Put/Call ratio
-
0.18
-
Number of buys
-
71
-
Number of sells
-
-34
-
Price
-
$12.73
Significant Holders of 89bio, Inc. - Common Stock (ETNB) as of Q4 2022
133 filings reported holding ETNB - 89bio, Inc. - Common Stock as of Q4 2022.
89bio, Inc. - Common Stock (ETNB) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3M shares
of 149M outstanding shares and own 31% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (8.96M shares), Deep Track Capital, LP (3.85M shares), ORBIMED ADVISORS LLC (3.66M shares), Cormorant Asset Management, LP (2.55M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.99M shares), Holocene Advisors, LP (1.9M shares), VANGUARD GROUP INC (1.58M shares), MILLENNIUM MANAGEMENT LLC (1.56M shares), MARSHALL WACE, LLP (1.49M shares), and Boxer Capital, LLC (1.4M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.